Weight Management Peptides
Peptides most studied for weight management, with mechanism, evidence, and regulatory status.
AOD 9604
A synthetic peptide fragment of human Growth Hormone designed to stimulate fat breakdown without affecting blood sugar o
Enicepatide (CT-388)
Enicepatide (CT-388) profile covering its dual GLP-1/GIP mechanism, Roche/Carmot Phase 3 obesity research status, potent
Exenatide
A GLP-1 receptor agonist originally derived from Gila monster exendin-4, used for type 2 diabetes and studied as a found
Liraglutide
A daily GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management, with a long record of clinica
MOTS-c
A mitochondrial-derived peptide studied for metabolic stress resistance, insulin sensitivity, and exercise-like signalin
Petrelintide
Petrelintide profile covering Zealand Pharma’s long-acting amylin analog, Phase 2 obesity research status, potential ben
Retatrutide
An investigational triple incretin receptor agonist being studied for obesity, fatty liver disease, and metabolic dysfun
Semaglutide
A highly successful, FDA-approved GLP-1 receptor agonist that regulates blood sugar, slows gastric emptying, and signifi
Tesamorelin
An FDA-approved, highly stable GHRH analog clinically proven to reduce stubborn visceral abdominal fat in HIV patients.
Tirzepatide
An FDA-approved incretin-based peptide medicine that activates both GIP and GLP-1 receptors for type 2 diabetes and chro